Quest Diagnostics (DGX) is back in focus after a busy February 10 update, combining higher quarterly and full year 2025 earnings, fresh 2026 guidance, a 7.5% dividend increase, and a larger share ...
Source LinkQuest Diagnostics (DGX) is back in focus after a busy February 10 update, combining higher quarterly and full year 2025 earnings, fresh 2026 guidance, a 7.5% dividend increase, and a larger share ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.